$NBIX insider trading

Over the last 12 months, Neurocrine Biosciences insiders reported no purchases and 24 sales totaling $36.3M across SEC Form 4 filings. 100% of those filings were made under pre-arranged 10b5-1 trading plans.

$36.3M
24
12
100%
Side
$100K$1.0M$10MJun '26JulAugSep
Cooke Julie
Norwalk Leslie V
Delaet Ingrid
Lippoldt Darin
Onyia Jude

All insider trades

Scroll the table sideways for price, value and marks.

Jul 28, 2026Norwalk Leslie V▼ Sale1,250$182.01$228K-44%
Jul 10, 2026Delaet Ingrid▼ Sale4,367$181.02$791K-21.2%
Jul 9, 2026Lippoldt Darin▼ Sale10,000$179.6$1.8M-15.4%
Jul 9, 2026Delaet Ingrid▼ Sale14,571$178.65$2.6M-47.3%
Jun 29, 2026Lippoldt Darin▼ Sale10,000$170.15$1.7M-15.4%
Jun 5, 2026SHERWIN STEPHEN A▼ Sale25,000$165.32$4.1M-61.2%
Jun 4, 2026Norwalk Leslie V▼ Sale1,250$168.06$210K-30.6%
Jun 2, 2026Cooke Julie▼ Sale3,520$158.59$558K-13.6%
Jun 2, 2026Cooke Julie▼ Sale9,521$157.62$1.5M-26.9%
Jun 2, 2026Cooke Julie▼ Sale4,216$156.77$661K-10.6%
Jun 2, 2026Cooke Julie▼ Sale5,466$155.46$850K-12.1%
Jun 2, 2026Cooke Julie▼ Sale14,214$154.83$2.2M-24%
Jun 1, 2026Onyia Jude▼ Sale11,000$160.25$1.8M-29.9%
May 29, 2026Delaet Ingrid▼ Sale2,261$156.71$354K-12.2%
May 27, 2026Onyia Jude▼ Sale11,000$155.53$1.7M-29.9%
May 26, 2026Boyer David W.▼ Sale3,888$156.64$609K-33.3%
Jan 16, 2026Gano Kyle▼ Sale36,400$132.7$4.8M-20.6%
Dec 16, 2025Norwalk Leslie V▼ Sale6,190$152.78$946K-49.8%
Dec 8, 2025Lippoldt Darin▼ Sale4,376$159.65$699K-9.2%
Dec 3, 2025LYONS GARY A▼ Sale15,000$152.61$2.3M-11.1%
Nov 28, 2025BENEVICH ERIC▼ Sale5,970$151.74$906K-11.7%
Nov 25, 2025MORROW GEORGE J▼ Sale15,000$143.37$2.2M-68%
Nov 5, 2025RASTETTER WILLIAM H▼ Sale18,000$151.82$2.7M-30.8%
Nov 4, 2025Gano Kyle▼ Sale300$141.97$43K-0.2%
Aug 7, 2025GORMAN KEVIN CHARLES▼ Sale106,322$126.41$13.4M-17.1%

Every $NBIX filing on this page is one API call away

The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Neurocrine Biosciences filings can reach your inbox instead.

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $NBIX feed.

NBIX Insider Trading — Neurocrine Biosciences Form 4 Buys & Sells | alphai